Assessment of a Clinical Trial–Derived Survival Model in Patients With Metastatic Castration-Resistant Prostate Cancer

IMPORTANCE: Randomized clinical trials (RCTs) are considered the criterion standard for clinical evidence. Despite their many benefits, RCTs have limitations, such as costliness, that may reduce the generalizability of their findings among diverse populations and routine care settings. OBJECTIVE: To...

Descripción completa

Detalles Bibliográficos
Autores principales: Coquet, Jean, Bievre, Nicolas, Billaut, Vincent, Seneviratne, Martin, Magnani, Christopher J., Bozkurt, Selen, Brooks, James D., Hernandez-Boussard, Tina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823224/
https://www.ncbi.nlm.nih.gov/pubmed/33481032
http://dx.doi.org/10.1001/jamanetworkopen.2020.31730

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823224/
https://www.ncbi.nlm.nih.gov/pubmed/33481032
http://dx.doi.org/10.1001/jamanetworkopen.2020.31730

Ejemplares similares